You are here: Industry Insights > oncology

News List

Verastem Oncology announces new strategic direction to advance its clinical development programmes pharmaceutical-business-review
March 06, 2020
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer ...
Voluntis and Bristol-Myers Squibb to co-develop digital therapeutics for oncology worldpharmanews
March 05, 2020
Voluntis, a leader in digital therapeutics, and Bristol-Myers Squibb Company announced a collaboration agreement to create and investigate digital therapeutic solutions that will support cancer patients.
Presage Receives FDA Clearance of First IND Application for CIVO Technology americanpharmaceuticalreview
January 15, 2020
Presage Biosciences announced the U.S. Food and Drug Administration (FDA) has approved its first Exploratory Investigational New Drug (IND) application for a Phase 0 study utilizing its CIVO platform.
Pfizer signs oncology agreement with STR-focused eFFECTOR pharmaceutical-technology
January 14, 2020
San Diego-based eFFECTOR has signed an exclusive worldwide license and collaboration agreement with Pfizer in the oncology field. The collaboration focuses on the development of small molecule inhibitors of eukaryotic initiation factor 4E (elF4E) ...
Evolving World of Pharma: Focal Points in Pharma for 2020 Sarah Harding
January 09, 2020
This year, the global pharmaceutical market has been predicted to reach US$1.3 trillion, but what is driving this continued growth, and what factors are likely to have a major impact on the pharma industry in 2020?
Amgen commences strategic collaboration with BeiGene to expand oncology presence in China worldpharmanews
January 07, 2020
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's second-largest pharmaceutical market.
Guardant Health AMEA wins this year's Growth Excellence Leadership Award by Frost & Sullivan En-CPhI.CN
November 22, 2019
Guardant Health AMEA has won Frost & Sullivan's Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology.
Collaborative oncology drugs review initiative announced by FDA europeanpharmaceuticalreview
September 19, 2019
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
FDA takes first action under new international collaboration with Australia and Canada worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
Pneumagen Appoints Scientific Advisory Board americanpharmaceuticalreview
September 03, 2019
Pneumagen announced appointments to its Scientific Advisory Board (SAB), adding expertise in the areas of respiratory disease, immunology and oncology.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page